Cite
Association of lipid-lowering drug targets with risk of cutaneous melanoma: a mendelian randomization study.
MLA
Miao, Lusheng, et al. “Association of Lipid-Lowering Drug Targets with Risk of Cutaneous Melanoma: A Mendelian Randomization Study.” BMC Cancer, vol. 24, no. 1, May 2024, p. 602. EBSCOhost, https://doi.org/10.1186/s12885-024-12366-8.
APA
Miao, L., Miao, T., Zhang, Y., & Hao, J. (2024). Association of lipid-lowering drug targets with risk of cutaneous melanoma: a mendelian randomization study. BMC Cancer, 24(1), 602. https://doi.org/10.1186/s12885-024-12366-8
Chicago
Miao, Lusheng, Taosheng Miao, Ying Zhang, and Jin Hao. 2024. “Association of Lipid-Lowering Drug Targets with Risk of Cutaneous Melanoma: A Mendelian Randomization Study.” BMC Cancer 24 (1): 602. doi:10.1186/s12885-024-12366-8.